BZI-Recaps

The earnings results for Fluent (NASDAQ:FLNT) for Q4 were made public on Monday, March 9, 2026 at 04:15 PM. Here's a comprehensive overview of the announcement. Earnings Fluent missed estimated earnings by -50.0%, reporting an EPS of $-0.09 versus an estimate of $-0.06. Revenue was down $3.59...

The Q4 earnings report for Zevra Therapeutics (NASDAQ:ZVRA) was released on Monday, March 9, 2026 at 04:05 PM. Here's what investors need to know about the latest announcement. Earnings Zevra Therapeutics beat estimated earnings by 280.0%, reporting an EPS of $0.19 versus an estimate of $0.05....

The Q4 earnings report for Repay Holdings (NASDAQ:RPAY) was released on Monday, March 9, 2026 at 04:05 PM. Here's what investors need to know about the latest announcement. Earnings Repay Holdings missed estimated earnings by 0.0%, reporting an EPS of $0.19 versus an estimate of $0.19. Revenue was...

The earnings results for Yext (NYSE:YEXT) for Q4 were made public on Monday, March 9, 2026 at 04:00 PM. Here's a comprehensive overview of the announcement. Earnings Yext beat estimated earnings by 27.27%, reporting an EPS of $0.14 versus an estimate of $0.11. Revenue was down $1.09 million from...

Myomo (AMEX:MYO) announced its Q4 earnings on Monday, March 9, 2026 at 04:06 PM. Here's a breakdown of the earnings report. Earnings Myomo missed estimated earnings by 0.0%, reporting an EPS of $-0.09 versus an estimate of $-0.09. Revenue was down $715 thousand from the same period last year....

The Q1 earnings report for Hewlett Packard (NYSE:HPE) was released on Monday, March 9, 2026 at 04:05 PM. Here's what investors need to know about the latest announcement. Earnings Hewlett Packard beat estimated earnings by 18.18%, reporting an EPS of $0.65 versus an estimate of $0.55. Revenue was...

The earnings results for Stereotaxis (AMEX:STXS) for Q4 were made public on Monday, March 9, 2026 at 04:01 PM. Here's a comprehensive overview of the announcement. Earnings Stereotaxis missed estimated earnings by 0.0%, reporting an EPS of $-0.06 versus an estimate of $-0.06. Revenue was up $2.30...

Voyager Therapeutics (NASDAQ:VYGR) released its Q4 earnings on Monday, March 9, 2026 at 04:00 PM. Here's what's important from the earnings announcement. Earnings Voyager Therapeutics beat estimated earnings by 11.54%, reporting an EPS of $-0.46 versus an estimate of $-0.52. Revenue was up $9.06...

Unusual Machines (AMEX:UMAC) announced its Q4 earnings on Monday, March 9, 2026 at 08:00 AM. Here's a breakdown of the earnings report. Earnings Unusual Machines missed estimated earnings by -414.29%, reporting an EPS of $-0.36 versus an estimate of $-0.07. Revenue was up $2.89 million from the...

Sharplink (NASDAQ:SBET) reported its Q4 earnings results on Monday, March 9, 2026 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Sharplink missed estimated earnings by -483.87%, reporting an EPS of $-1.19 versus an estimate of $0.31. Revenue was up $14.95 million...

Global Business Travel (NYSE:GBTG) reported its Q4 earnings results on Monday, March 9, 2026 at 07:05 AM. Here's what investors need to know about the announcement. Earnings Global Business Travel beat estimated earnings by 36.36%, reporting an EPS of $0.15 versus an estimate of $0.11. Revenue was...

Corbus Pharmaceuticals (NASDAQ:CRBP) announced its Q4 earnings on Monday, March 9, 2026 at 07:30 AM. Here's a breakdown of the earnings report. Earnings Corbus Pharmaceuticals beat estimated earnings by 24.7%, reporting an EPS of $-1.25 versus an estimate of $-1.66. Revenue was down $0 from the...

Cartesian Therapeutics (NASDAQ:RNAC) just disclosed its Q4 earnings on Monday, March 9, 2026 at 07:00 AM. Here's a brief overview of the earnings report. Earnings Cartesian Therapeutics missed estimated earnings by -73.75%, reporting an EPS of $-1.39 versus an estimate of $-0.8. Revenue was up $1....

Dianthus Therapeutics (NASDAQ:DNTH) announced its Q4 earnings on Monday, March 9, 2026 at 07:09 AM. Here's a breakdown of the earnings report. Earnings Dianthus Therapeutics missed estimated earnings by -41.58%, reporting an EPS of $-1.43 versus an estimate of $-1.01. Revenue was down $1.04 million...

ARS Pharmaceuticals (NASDAQ:SPRY) reported its Q4 earnings results on Monday, March 9, 2026 at 07:00 AM. Here's what investors need to know about the announcement. Earnings ARS Pharmaceuticals beat estimated earnings by 8.7%, reporting an EPS of $-0.42 versus an estimate of $-0.46. Revenue was down...